Dr. William Williams, CEO of BriaCell Therapeutics Corp., a company immuno-oncology focused biotechnology company developing a targeted and safe approach to the management of cancer joins eHealth Radio and the Cancer Information and Health News Channels.
Listen to host Eric Michaels & guest Dr. William Williams discuss the following:
Dr. William Williams is a seasoned biopharmaceutical executive with over 35 years of industry and academic expertise, including significant clinical management in multinational pharmaceutical companies. Dr. Williams served as VP of Exploratory Development at Incyte Corporation from 2005 - 2016. There he facilitated entry of over 20 compounds into the clinic, including ruxolitinib (Jakafi), baricitinib, and epacadostat.
Dr. Williams served as Head of Rheumatology Research at the University of Pennsylvania, ran a major research program in receptor biology, including developing bioactive peptides that mimicked granulocyte-macrophage colony-stimulating factor (GM-CSF), a known stimulant of the immune system. He collaborated with David B. Weiner, Ph.D., a well-known leader in immuno-oncology and vaccine research, in the development of DNA vaccines and was able to bring novel DNA vaccines into the clinic for the treatment of cutaneous T cell lymphoma.
Dr. Williams earned his BSc. in Chemistry and Biotechnology from Massachusetts Institute of Technology and Medical Doctorate from Tufts University School of Medicine. Following his residency at the Boston VA Medical Center, Dr. Williams completed fellowship training in Rheumatology and Cellular Immunology at the University of Missouri. He then joined the molecular immunology laboratory of Mark I. Greene, MD, PhD, FRCP, at the University of Pennsylvania, developed novel methods of bioactive peptide design, and collaborated in the study of the activation of the p185/Human epidermal growth factor receptor 2 (HER2) receptor. HER-2 is a protein which is known to promote the growth of cancer cells. Dr. Williams is the named author at over 130 peer reviewed publications, over 15 patents and numerous Investigational New Drugs (INDs) and NDAs.
Website: www.briacell.com
AscellaHealth’s Craig Caceci, Executive Vice President and Managing Director, Terebellum
What Cats Are Really Into and How To Keep Them Well Trained
Hair Loss in men and women with Dr. Nettles
Proven Steps for Deep Restful Sleep & Avoid Sleepless Nights for Good
Global Game Changers Shares 6 Emotion Management Tips for Kids
Plant-based Soups That Provide the Nutrients Our Bodies Need
How to Change SAD Eating Habits
OB/GYNs Look to New Reproductive Technology to Meet Demand for Achieving Pregnancy
Rose Mactutus Booze: The Long-Term Effects of COVID on the Brain and the Impact to Society
More Consumers are Buying Frozen Seafood to Cook due to Seafood’s Health Benefits – Why Frozen is the New Fresh
Beautifi - Making Health & Beauty Affordable
Dr. Michael Turner: Your go to for all things health and wellness
Innovative Market Access and Product Life Cycle Solutions for Life Sciences with AscellaHealth
An Opportunity to Lower Medical Costs
Masks are coming off in some states and COVID-19 is here to stay
The First New Ischemic Stroke Treatment in 25 years by DiaMedica Therapeutics
How to Camouflage a Virus: The Latest in Gene Therapy with Genine Winslow
Innovative and Better for your Passsover from Kosher.com: Manischewitz and other great Kosher Brands
Vetster and the Pet Tele-health Medicine Market with Dr. Sarah Machell
How Rise Medical is Making Sexual Wellness Mainstream with CEO Dan Markel
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
URGENŤÁCI